WeChat Mini Program
Old Version Features
Research Interests

Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study
Alper Topal,Goncagul Akdag,Sedat Yildirim,Oguzcan Kinikoglu,Deniz Isik, Gizem Yildirim,Salih Tunbekici, Fatih Kus, Aydın Acarbay, Murad Guliyev, Nargiz Majidova, Yasin Kutlu,Mustafa Erman,Hatice Odabas,Nedim Turan,Nuri Karadurmus
Medicina (Kaunas, Lithuania)no. 3 (2025)
Cited0Views0WOSBibtex
0
0
Comparison of Paclitaxel and Docetaxel in Dual HER2 Blockade: Efficacy and Safety in Neoadjuvant Treatment of HER2-positive Breast Cancer
Ezgi Turkoglu, Goncagul Akdag Topal,Sedat Yildirim,Oguzcan Kinikoglu, Nisanur Sariyar Busery, Miray Aydogan, Hacer Sahika Yildiz, Seval Orman, Ayberk Bayramgil, Tugce Kubra Gunes, Mustafa Alperen Tunc, Nargiz Majidova,Deniz Isik, Sermin Kokten,Hatice Odabas,Nedim Turan
Breast Cancer Research and Treatmentno. 3 (2025): 743-752
Cited0Views0WOSBibtex
0
0
The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer
Ezgi Turkoglu, Goncagul Akdag Topal,Sedat Yıldırım,Oguzcan Kınıkoglu, Nisanur Sarıyar Busery, Tugba Kaya, Hacer Sahika Yıldız, Furkan Turkoglu, Cihad Tatar,Abdullah Sakin,Deniz Isık, Seval Ay Ersoy, Tugba Basoglu,Hatice Odabas,Nedim Turan
Medicina (Kaunas, Lithuania)no. 6 (2025)
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 30

#Citation: 17

H-Index: 2

G-Index: 3

Sociability: 5

Diversity: 1

Activity: 2

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn